Bone problems: latest news

Bone problems resources

  • Longer-term side-effects

    Effective HIV treatment has significantly reduced the risk of serious kidney disease in people with HIV. However, most anti-HIV drugs can cause some damage to the kidneys, so...

    From: Booklets

    Information level Level 2
  • Other tests

    Blood pressure is the force that the beating heart causes in the arteries, veins, and blood vessels that carry blood around the body. Blood pressure is measured...

    From: Booklets

    Information level Level 2
  • Side effects

    The most common side effects are the result of your body getting used to a new drug. After a few weeks, these side effects usually...

    From: The basics

    Information level Level 1
  • HIV treatment, metabolic changes and ageing

    Anti-HIV drugs can cause changes inside your body, known as metabolic changes. These can include: changes to blood fats (also called lipids), such as having too much low-density (LDL, or...

    From: Booklets

    Information level Level 2
  • Bone loss

    Osteoporosis has traditionally been a disease affecting women past the age of menopause. However, studies have established that osteoporosis is also common amongst HIV-positive men...

    From: HIV treatments directory

    Information level Level 4
  • Osteonecrosis

    Osteonecrosis, literally 'bone death', is caused by poor blood supply to an area of bone. Like the other bone disorder osteoporosis, osteonecrosis has only recently...

    From: HIV treatments directory

    Information level Level 4
  • Osteoporosis and osteopenia

    Osteoporosis is a condition where the bones lose mass and density. It is commonly referred to as 'thinning of the bones' and occurs most commonly...

    From: HIV treatments directory

    Information level Level 4

Bone problems features

Bone problems news from aidsmap

More news

Bone problems news selected from other sources

  • CROI 2014: Researchers discuss HIV, aging, and frailty

    People living with HIV are at greater risk of geriatric syndromes such as frailty and difficulty with daily activities than HIV negative people of the same age -- and this can have a significant effect upon their quality of life as they age, according to several studies presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI 2014) last month in Boston.

    08 April 2014 | HIVandHepatitis.com
  • HIV Drug Linked to Low Bone Density in Babies

    In a cohort study, babies of mothers taking tenofovir (Viread) had an average whole-body bone mineral content about 8 grams less than babies whose mothers did not use the drug, according to George Siberry, MD, of the National Institute of Child Health and Human Development in Bethesda, Md

    07 March 2014 | MedPage Today
  • Primary care key to management of patients with HIV infection

    The HIV Medicine Association of the Infectious Diseases Society of America has updated its HIV care guidelines to reflect the fact that people with HIV are now living normal life spans, and their physicians need to focus on preventive care, including screening for high cholesterol, diabetes and osteoporosis.

    14 November 2013 | Eurekalert Inf Dis
  • TDF/FTC-to-ABC/3TC switch maintains viral suppression, eases bone markers

    A switch from tenofovir/emtricitabine (TDF/FTC) to abacavir/lamivudine (ABC/3TC), both with atazanavir/ritonavir, maintained viral suppression through 48 weeks in a noninferiority analysis and improved bone and kidney markers. Four people in the ABC/3TC arm (2%) and one in the TDF/FTC arm (1%) had study-defined virologic failure by week 48.

    19 September 2013 | NATAP
  • Bone loss and fracture risk are 'modest' among HIV+ people, linked to tenofovir, smoking, and HCV

    Continued bone loss among HIV positive men with osteopenia was modest overall, but about 25% of those taking tenofovir (Viread, also in 4 antiretroviral coformulations) experienced significant loss, according to a recent study. A related meta-analysis found that HIV infection is associated with a modest likelihood of new fractures, with smoking and hepatitis C virus (HCV) coinfection further increasing the risk.

    07 June 2013 | HIVandHepatitis.com
  • Bone mineral density below normal in children infected early with HIV

    Bone mineral density was below the general population norm in US children perinatally infected with HIV and lower than in children perinatally exposed to HIV but uninfected.

    21 January 2013 | International AIDS Society
  • HIV treatment interruption associated with reduced bone loss in SMART trial

    People who stopped antiretroviral therapy in the SMART trial had less bone loss and lower levels of bone metabolism biomarkers than people who remained on continuous antiretroviral therapy (ART), according to a report in the January 8, 2013, advance edition of Journal of Bone Mineral Research.

    16 January 2013 | HIVandHepatitis.com
  • Activist discusses challenge of growing old with HIV

    Old age comes faster and hits harder for those infected with HIV, a fact aging health activist Ron Swanda knows all too well.

    30 November 2012 | AFP
  • Weekly alendronate improves bone density in adults taking ART

    Alendronate significantly improved bone mineral density through 96 weeks of treatment in a double-blind placebo-controlled trial that enrolled adults with osteoporosis while taking antiretroviral therapy (ART).

    30 August 2012 | International AIDS Society
  • High Dose Vitamin D Prevents Fractures

    High doses of vitamin D prevent fractures in older people – as long as they take the substance regularly.

    05 July 2012 | Medical News Today
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also